Mark Feinberg is President and CEO of the International Vaccine Initiative (IAVI). Prior to joining IAVI in September 2015, he served as Chief Public Health and Science Officer for Merck Vaccines. Prior to joining Merck in 2004, Dr. Feinberg worked for over 20 years in both academia and government where he was actively engaged in basic and clinical research, patient care and health care policy--with a primary focus on HIV/AIDS pathogenesis, treatment and prevention research and on the biology of emerging infectious diseases.
Dr. Feinberg received his BA from the University of Pennsylvania and his MD and PhD degrees from Stanford University. He pursued a post-graduate medical training in Internal Medicine at the Brigham and Women’s Hospital and postdoctoral fellowship training in the laboratory of Dr. David Baltimore at the Whitehead Institute. Dr. Feinberg has served on the faculty of the University of California, San Francisco and the Emory University School of Medicine, and as a Medical Officer in the Office of AIDS Research at the National Institutes of Health. He was a Fellow in the Advanced Leadership Initiative at Harvard University from 2012-14. Dr. Feinberg is a Fellow of the American College of Physicians, a member of the Council on Foreign Relations and the Association of American Physicians. He currently serves as Chair of the Interim Scientific Advisory Committee of the Collaboration for Epidemic Preparedness Innovations.